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Introduction
The naturally occuring ergot alkaloids of the fungus,
Claviceps purpurea, and their many derivatives have been of
neuropharmacological interest for many years because of their
ability to affect peripheral and central adrenergic and
serotonergic systems.

More recently, selected compounds

such as lergotrile (2-chloro-6-methyl ergoline-8-betaacetonitrile) and bromocryptine (2-bromo-alpha-ergocryptine),
have been given additional attention due to their possible
therapeutic potential in the treatment of parkinson's
disease, acromegaly and other disorders.

There have been

considerable data published attempting to establish the
mechanism(s) whereby the ergot compounds exert their effects.
A large portion of these experiments involves the interaction of ergot compounds with dopaminergic systems.

This

is a logical course of study, since many of the actions of
the ergot compounds mimic the actions of compounds known to
affect dopaminergic neurons, e.g. antagonists such as the

1

?

phencthieczines and butyrophenone" . and agonists such as
levodopa and apomorphine.

In the last decade, much

attention also has been focused on the r•ole of serotonin
(5-hydroxytryptamine) in the mediation of dopaminergic
systems.

There have been many confl:tcting reports pub-

lished as to the role of serotonin but it is still uncertain whether or not serotonin does indeed play a role. The
present study investigates two dopaminergic effects of the
standard dopamine agonist aporr.orphine and the ergoline
lergotrile

and the similarities or differences that

exist when serotonergic fur.ctl':lr is a2.tered.
Literature Survey
1. Hypothermic action of

apomorp~ine

An effect of apomorphine en rodent thermoregulator•y
fur.ction <las first descr·:Lbed by Lapin and Samsono7a (1968a,
~968b

l.

The first convincing evidence that linked drugs

which stimulate dopamine receptors wi.th a decrease in core
temperature. in rats and mice was presented in 1972 (Kruk,
l972; J'i'uxe and Sjoqvist, 1972).

Since that time, apomor-

ph:l-:ne has been cons:t.stently reported to cause a dose-related
hypothermia. in rats and mice using a variety of injection
techniques (Barnett et al., 1972; Chie1 et al., 1974; Ary
et al., ~977; Cox and Lee, 1978).

Kruk (1972) found that

dopamine, amphetamine and apomorphine injected intracerebroventricularly into rats, ca.us.ed a fall in core temperature
accompanied by a rise :tn s.k:tn tempe.rature.

A maximum d::'op

of about one degree centigrade was oht<erved with all three

3

drugs, this effect be.ing completely antagonized by the
specific dopamine antagonist pimozide.

Fuxe and Sjoqvist

(1972) obtained a drop of 3° to 4° C in the body temperature
of mice administered apomorphine by intraperitoneal injection, and this effect was blocked by a dose of haloperidol
that had no effect on body temperature itself.

The nor-

adrenaline antagonist phenoxybenzamine and the anticholiner- - - - - - _g-i-c-a-ge-:t:::t-t-a-t-:P-o-~-i-r:J.-e-ta-1-1S-d.-t-o-Q-1-o-Gk-t-h-e-b_y-p.o-t-l~e-~m-1-c-a.c-t-i-on.------

of apomorphine, thereby precluding alpha adrenergic or
muscarini.c cholinergic mechanisms of action for apomorphine.
These observations suggest that the hypothermic action of
apomorphine is exclusively mediated by dopamine receptors.
The apparent mechanism of action of apomorphine at the
dopamine receptor had been determined several years earlier
by Ernst (1967} and Anden (19671.

Apomorphine-induced

effects were found to be independent of exogenous catecholami.ne release, which is contrary to the action of amphetamine, which produced its action through the release of
endogenous catecholamines.

It was concluded that the action

of apomorphine was that of a direct agonistic action on the
receptor structure.

Thus it appears that apomorphine

induces hypothermia by a direct stimulation of dopamine
receptors.
It has. long been recognized that the preoptic anterior
hypothalamus has an important thermoregulatory function in
warm~blooded

animals (Reid et al., 19681.

Utilizing central

microinjection techniques, it has been determined that the

4

site of action of apomorphine (Cox and Lee, 19 78} and
dopamine CQuock and Gale, 19741 is a well defined area of
dopamine receptors in the preoptic anterior hypothalamus.
This area was- found to lie sensitive to th_e antagonistic
acti.on of haloperidol in both studies.
Tolerance to the hypothermic action of apomorphine has
been demonstrated.

Daily intraperi.toneal injections of

response of subsequent injections of apomorphine and other
dopamine agonists (Chiel et al., 197 4 2 •

It was suggested

that tolerance to the hypothermic effects was due at least_
in part to a decrease in sensitivity of the dopamine receptors involved.

Tolerance to the hypothermic action of apo-

morphine has also been demonstrated to occur after chronic
rostral hypothalamic injections CAry et al,, 1977), but
repeated injections into the lateral ventricle fail to produce tolerance . Therefore, the possibility of two different
types- of dopamine receptors at two different sites has been
suggested

those surrounding the lateral ventricles being

resistant to tolerance,
2, Apomorphine-Induced Stereotypic Behavior
It has been known for over one hundred years. that apomorphine, administered by a variety of routes, produces a
behavioral syndrome i.n rats consisting of continuous, purposeless, compulsive acti.ons (Harnack, 18741.

At threshold

doses, an increase in exploratory activi.ty coupled with discontinuous sniffing is manifested.

With increased dosage,

5

normal activities s.uch. as grooming and feeding are extinguished and replaced with continuous sniffing, accompanied
by small, repetitive head movements.

High doses of apomor-

phine elicit a continuous gnawing, biting and licking
response and the rat restricts its locomotion to a very
small area.

The nature of this behavior jus·tifies the term

''stereotypy, 11 which has been applied to it (DiChiara and
_ _ _ _ __j_r--e-s~s-a--,-l--9-7-8-}-;-a-S~t-&-~&:-G-t-¥-P-Y-P...a-s·-Q-e-e-n-Gl-e-S-Q-I!-:kG-e-Q-i-n-ma-n-¥-S-pe-G-1-e-s-----

including rodents, cats, dogs, rabbits, pigeons and others
(Randrup and Munkvad, l967; DiChiara and Gessa, 1978).
Such stereotyped behavior in rodents can be quantified
according to the dose-related appearance of one or more of
the behavioral components (Ernst, l967; Costall and Naylor,

1972l.

Such scoring scales rate smiffing behavior (with

locomotion) lowest while rating continuous gnawing (with
little or no locomotion) the highest.

Details of one such

scoring system are shown in Table I. The appearance of the
sniffing at low doses and gnawing at higher doses appears to
be directly correlated with the appearance of apomorphine
in brain tissue following peripheral injection (Butterworth
and Barbeau, l975l.

Other scoring systems exist for apornor-

phine-induced stereotypy, e,g. "gnaw compulsion" syndrome
was considered to be. present (Ernst, l969) when rats gnaw
at the wire mesh on the bottom of the cage for at least half
a minute and, when loosened from the wire, start gnawing
again.

Others have used a quantal approach to determine the

pre.s'ence of s·tereotyped behavior (Goetz and Klawans, 1974;

~~~

--------------

-----

-

Table l -- Stereotyped behavior rating scale used in
the present study

0 = Rats exhibiting no stereotyped behavior; behavior
is indistinguishable from that of control animals.
1 = Rats exhibiting periodic sniffing and repetitive
head and limb movements.
_______2~-=-'---Rat_S_e.xhi_b_it_ing_c_ont_inuo_us_snif'f'ing_and_r_e_p_e_t_it_iye,_______
head and limb movements; exploratory activity is
also present.
3 = Rats exhibiting occasional licking, biting or
gnawing; exploratory activity is also present.
4 = Rats exhibiting persistent and intense licking,
biting or gnawing; locomotion is restricted to
a small area.
5 = Rats exhibiting persistent and intense licking,
biting or gnawing restricted to one location.
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Jacobs, 1974)_,

It has been observed that the presence of

wooden shavings on the cage floor facilitates the gnawing
component of stereotypy produced by intermediate doses of
apomorphine, and that distracting stimuli, such as loud
noise, inhibit this phenomenon (_DiCh.iara and Gessa, 1978)_.
Ernst (19672 concluded that apomorphine produces stereotyped behavior in rats by direct stimulation of the dopamine
----~.L ·e-c-e~p-t-o-rs-1-o-c-a-t-e.-d-i-n-t--he-n-e-o-s-t-r-i--a-t-l::bu-.-~h-i-s-R-y-13-e-t-Re-s-i-s-i-s:------

supported by several other studies that have been reported.
In the next three paragraphs these studies will be discussed.
The ability of apomorphine to induce stereotyped behavior has been shown to be abolished by lesions of the corpus
striatum (Amsler, l923; Wolfarth et al., 1973).

By stereo-

taxically implanting crystalline apomorphine or L-dopa into
the brain of rats, Ernst and Smelik (1966) discovered that
areas producing stereotype.d behavior were the dorsal part
of the caudate nucleus and the globus pallidum.

No stereo-

typed behavior was produced by implants into the ventral
part of the caudate nucleus, in the region medial to the
caudate nucleus (nucleus lateralis septi), in subthalamic
structures, or in the substantia nigra.
As noted earlier, evidence for the dlrect act ion of
apomorphine on dopamine receptors 1'/as presented by Ernst

09_672_ and Ande.n

C19~67L

1-dopa, apomorphine and amphet-

amine all produce similar stereotyped behavior in rats.
Depletion of brain amines by alpha-methyldopa failed to
block_ apomorphine-induced stereotypy but profoundly antagon-

8

ized amphetamine-induced stereotypy, · Alpha-methyl tyrosine and res'erpine produce the same results.

Fog C1967l

demonstrated that intracerebral microinjections of dopamine
into the corpus striatum restore amphetamine-induced stereotypy that has· been inhibited by alpha-methyl tyrosine. This
strongly suggests that apomorphine does not act by

dopamine

J:'e.lease, but has a dopamine--like effect on th_e receptor

------.a-t-;r:-u-c-t-u-r-e-.-Am-p-he-t-am1::n-e-wo-u-J:-d-ap-p-e-a-r-t-o-a-c-t-v-1--a-t-h-e-r-e-i-e-a-s-e·-----

of endogenous amines.

Further evidence of this is the ob-·

servation that monamine oxidase inhibitors can potentiate
the behavioral effects of amphetamine (Ernst, 19671 and 1-.
dopa but exert no effect on apomorphine-induced stereotyped
behavior.

Apomo:r"phine does have structural similarities to

dopa, and it has been suggested that the presence of hydroxyl
groups at the para- and meta- positions of the phenol ring
in the phenol-ethylamine configuration is obligatory for a
direct action on gnawing behavior (Ernst, 1967). Apomorphine
poss·esses thi.s catechol configuration; amphetamine does not
CFig. 12.
Further suppo:r"t for the dopaminergic nature of apomorphine is that among neuroleptics, the most powerful antagonists; of apomorphine are haloperidol, spiroperidol and pimozide,

These compounds are reported to be pure dopamine

rece.ptor blockers at doses effective in antagonizing apomorphine-induced stereotyped behavior (DiChiara and Gessa, 1978).
Jn contrast to the above widely accepted theories on
apomo:r'phine acti.on, it has been shown that lesions of

9

HO
HO

oDOPAMINE

CH2fH-NH 2
CH
3

AMPHETAMINE

APOMORPHINE

Figure 1 -- The structural relationships between dopamine,
amphetamine, apomorphine and lergotrile.

dopaminergic tracts or nerve cells are effective in abolishing or decreasing apomorphine-induced stereotypy (Costall
and Naylor, 1972)_.

This would indicate that apomorphine-

induced stereotypy requires the presence of intact dopamine.rgic terminals, and that apomorphine produces stereotypy
via some presynaptic mechanism.

Further evidence indicating

a presynaptic action for apomorphine is that disruption of
-----~L"'l-t-r-ane-l:l-r-e-n-a-l-a-m-i-ne-s-t-e-re~s-b.-y-e:X-y-})-e-r-t-i-ne-an-S.-RG-G-4-=-:l-2-B-4-------

(catecholamine depletors2 has been shown to reduce or
a.bolish the stereotypic effects of apomorphine (Costall and
Naylor, 1£73al.

The electrolytic lesion techniques employed

by Co stall and Naylor (1972, 1273b )_ have come under critici.sm recently by DiChiara and Gessa (19781.

Their studies

are in disagreement wi):;h data obtained by specific chemolytic destruction of dopamine terminals with 6-hydroxydopami.ne (Schoenfeld and Uretsky,

~9722_.

Reasons suggested

for this descrepancy include the incompleteness of the
electrolytic lesions or interference with other non-dopaminergic nerve tracts necessary for the expression of apomorphine-induced stereotypy.
;Ei'urth.er evidence for the presynaptic activity of apomorphine, but not intrtnsically link.ed to s.tereotypy, is the
ability of apomorphine to inhibit tyrosine hydroxylase, the
enzyme responsible for converting tyrosine to dopa (Goldstein
et al., 19_70}.

It has been :proposed that a negative feed-

back mechani.sm exi.sts in dopaininergic neurons, and that the
sttmulation of dopamine terminals by apomorphine activates

this mechanism (Kehr et al., 1972 L

Studies determining

the rate of disappearance of dopamine after tyrosine hydroxylase. inhibition with alpha-methyltyrosine have shown that
apo:rnorphine consistently causes a decrease in the rate of
disappearance of dopamine (Anden et al., 1967; Butcher and
Anden, 1969)..

Goldstein and colleagues (1970) found that

apomorphine inh.ibited tyrosine hydroxylase as well as the
------:&-y~B-t--fiB-a-i-s~e-f-ei-B-p-a-m-1-ne-f-re-m-t-y-r<:J-s-i-ae-i-B-s-t-r-:i..-a-t--a-l-s-l-i-e-e-s----.-------II!-R-e'-----

addition of haloperidol to the preparation did not affect
the inhibitory effect of apomorphine.

This experiment

indi.cates that tbe inhibitory effectiveness. of apomorphine
on striatal slices is not due to stimulation of dopamine
receptors:, but due to a direct action on tyrosine hydroxylase.

The catech,el structure of apomorphine supports this

theory.
Costall and Naylor (12752 have attempted to differentiate pharmacologi.cally and anatomically two components of
stereotyped behavior, a low-intensity component (sniffing
and repetitive move:rnentsl and a high-intensity component
(_gnawi.ngL

As :mentioned earlier, low dos.es of apomorphine

cause sniffing and repetitive head and limb movements, whereas high doses elici.t intensive gnawing.

Intracerebral

application of dopamine to the tuberculu:rn olfactoriu:rn and
nucleus accumb.ens s.epti produces sniffing and movements
characteristi.c of the low-intensity component.

Lesions of

these areas were effective in· ;reducing the stereotyped
sniffing and head and li:rnb :movements induced by apomorphine.

~2

The substantia nigra and nucleus amygdaloideus centralis
were determined to be the effectors for the high-intensity
component using the same intracerebral application and
lesion techniques-.

It has become apparent from these

findings- that other brain structures and pathways are also
important in the expression of the stereotypic effects of
apomorphine besides those of th_e neostriatum (Ernst and
------&me-l-1-k , J:-9-6-6:_).-.-P-a--l-e-o-s.-t-:r-i-a-t-a-J..-s-t-r·u-c-t-u-r-e-s-Enu--c-1-e-u-s-pa-l-l-:tdus ) 1 - - - - -

and mesolimbic areas (tub_erculum olfactorium, nucleus amygdaloideus centralis and lateralis, nucleus accumbens septi)
as well as those of the neos.triatum (caudate nucleus and
putamen) all appear to have important functions in the full
expression of apomorphine-induced stereotypic behavior.
3. The Role of Serotonin in Thermal Regulation and Stereotypy
There exists considerable evi.dence that serotonin plays
a role in many central nervous system functions such as
temperature regulation, neuroendocrine regulation, sleep,
extrapyramidal function and behavior (Chase and Murphy, 1973).
Recently it has been postulated that serotonin may have a
function in regulating or mediating
dopaminomimetics such as apomorphine,

the central effects of
Conflicting reports

preclude the formulation of a single theory to explain the
role that serot.onin ·may play in these systems
Attempts to evaluate the role serotonin may play in the
central nervous system or in the action of dopamine agonists
may be grouped into four approaches.

The first approach is

biochemical, whereby attempts are made to increase or

decreas.e brain serotonin.

Systemically administered pre-

cursors of s·erotonin (L-tryptopban and 5-hydroxytryptophan)
are believed to increas.e brain serotonin and neural transmi.ssion, but evi.dence e:xists that this method may also interfere with other catecholamines (Chase and Murphy, 1973)..
The opposi.te approach is to administer a drug that is
believed to decrease brain serotonin and neural transmission,

- - - - - - ' P a-J?-a-e-R-±-G-P-e-:F>R-e-R-y-l-a-1-a-B±-B-e-i-s-a-B-i-B-PL-i-B--i-t-e-r-e-f-t-rs-13-t-e-FJ-B.-a-B--------

hydroxylase and leads to a profound depletion of brain serotonin (Koe and Weissman, .1966[.

However, it has been shown

that parachlorophenylalanine also lowers the levels of
other brain amines including norepinephrine and dopamine
l"ragliamonte et al., .1973 2..
A pharmacologic approach is to use selective blocking
agents for serotonin receptors in the brain.

Drugs such as

cyproheptadine, cinanseri.n and methysergide are believed to
block serotonin receptors directly.

The major difficulty

with. the.se pharmacologically based investigations is
;finding a drug that acts exclusively on serotonin neurons.
)?hysical techniques have been utilize.d for the in vitro
study of serotonin function.

Le.sions of the midbrain raphe

are reported to deplete markedly the serotonin concentration
of ;forebrain (Kostowski et al., 1968l, whereas electrical
stimulation of this. area accelerates the synthesis and
releas.e of serotonin (Kostowski et al., .1969}.

As with

pharmacological te.chniques, physical intervention is somewhat nonspecific and may a:('fect non-serotonergic nerve

14

fibers that tr.avers.e the raphe nucleus. (Chase and Murphy,
1973 2.
The fourth major approach to the study of serotonin
Jl)echaniS1llS involves histofluorescent techniques.

By

meas:uring the brain leve.l$ of serotonin or 5-hydroxyindoleacetic acid, its: principal deaminated metabolite, the steady
state or turnover rate of serotonin can be monitored, and
-----~tn-e-:re.-l-a-t-:i:-v-e-a-e-t-i~v-a-t-i-e-n-o-f-s-e-r-o-t:o-n--i-n-ne-u-re-n-s-e-a-n-b-e-e-s

t ii~-~.- - - - -

mated (Tozer et al,, l966L
It has been reported that apomorphine increases serotoni.n turnover CScheel-Kruger and H.asselager, 1974; Grabow.ska, 1975; Maj, l975l.

Apomorphine has been found to

accelerate the disappearance of 5-hydroxyindoleacetic acid
from the brain of pargyline -pretreated (a MAO inhibitor)
rats as well as to facilitate the depletion of brain serotonin caused by synthesis inhib.i ti.on (Grabowska, 1975).
Depletion of brain serotonin was abolished when rats were
treated with the dopamine antagoni.st, spiroperidol. ApomorphJne has been reported to increase brain serotonin and
5-hydroxyindole.acetic acid levels, accelerate the disappearance rate of serotonin after synthesis inhibition with
· alpha-propyldopacetamide, and intensify serotonin fluore,wense in raphe nuclei. CMaj, 19752.

Dopami.ne blockers

Cspi.roperi.dol and piJI)ozide t counteract these effects of
apomorphine, and th.is has led to the suggestion that these
agents influence serotonin neurons through. a secondary mechanis1!J, with the primary effects being directed at dopamine

receptors.

Further

experi~ents

have supported this theory.

Apomorphine will increase the concentration of serotonin
and

5~hydroxyindoleacetic

mesencephalon of

nor~al

acid in the raphe region in the

rats nut not in rats with a mesen-

cephalic-diencephal:l:c transection (Granowska et al., 1976).
This tra.nsection interrupts the des·ce.nding pathway originating from dopamine structures of the forebrain.

Transec-

tion alone was reported to cause no change in raphe serotonin
or 5-hydroxyindolea.cetic acid,

Therefore, it appears that

apomorphine can activate serotonin neurons indirectly, This
act:tvation of serotonergic neurons may be important in the·
mediation of some of the pharmacological effects of apomorphine and other dopaminom:tmet:tcs.
Serotonin a.ppears to also have a critical role in the
complex network of neural factors which regulate body temperature.

Brain serotonin has been shown to increase in the

ra.t during heat stress (Reid et al., 1968) and it has been
propose.d that central serotonin pathways may be involved
:tn the res·pons·e to heat stress in the rat.
Seyeral s.tud:tes indicate that apomorphine-induced
thermal effects have a serotonin link.

Ni.dbrain raphe

lesions have. been sh.own to attenuate the hypothermic effects
of apomorphine in rats CClrabowska et al., 1974)_. Selective
chemolytic des.·truction of serotonin neurons with 5, 6-dihydroxytryptamine, as well as serotonin depletion with parach.lorophenylalanine, has been reported to strongly inhibit

the hyperthermia induced by apomorphine. and other dopamine
agonists· in rabbits (Carruba ·et al., 19:781.

Intrahypo-

thala!l)ic pretreatment with. cyproh.eptadine or methysergide
has b.een shown to block the h;ypothermic effect of dopamine
agonists (Cox and Lee, 1979l. LSD (lysergic acid diethyl-

-

"'

amide l will inhibit apomorphine-induced hypothermia and
this effect is beli.eved to b.e due to stab.ilization of sero------1toR4-n-w-3::-t-h-:1:-n-t-he-recept-or-t.Grabows-k-a-e-t-a-l----.----,-----l-9-7-3-l-.-lp-fl-u-s:-.,c------

strong evidence indi.cates that apomorphine and other
dopaminomimetics may mediate thermal effects in mammals
through a serotonergic link.
While there i.s general agreement on a serotonergic
link in apomorphine-induced hypothermia, apomorphine-induced
stereotypy does not enjoy such. agreement.

Studies have

shown that an increase in brain serotonin induced by 5hydroxytryptophan or l-tryptophan or a reduction in brain
serotonin with parachlorophenylalanine has no effect on
apomorphine-i.nduced stereotypy (Rotrosen et al., 1972;
Baldessarini et al., 19752..

The serotonin lesioning agents

5,6- or 5,7-dihydroxytryptamine (Baldessarini et al., 19752
and the serotonin antagonist methysergide (Rotroseri et al.,
~9:72 I

have. also been reported to have no effect on apomor-

phine.-induced stereotypy.
Certain reports i.ndicate that a decrease in serotonin
concentration or a b.lockade of serotonin receptors can patentiate apomorphine-induced stereotypy (Weiner et· al,, 1975;
Jllolgilnicka et· al,

1

19.771,

Treatments found to potentiate

apomorphine~induce.d

stere.otypy included parachlorophenyl-

alanine, cyproheptadine, methysergide and methergoline,
The administrati.on of 5-hydroxytryptophan was found to
inhib.it apomorphine-induced stereotypy (Weiner et al. ,1975).
Consequently, it has- been suggested that s·erotonin plays an
antagoni.s·tic role to that of dopamine in stereotyped
ior (Molg1lnicka et al., 1977),

behav~

In agreement with this,

----~me-t--R-a-mi3h~e-t--a-m~ae-~-1-n8.-ue-e-El-$-t--er-e-e-t--y-J?y-ha-s-S-e-e-R-f8B-B-El-t-e-8-e------

inhibited by 1-tryptophan treatment and potentiated by
parachlorophenylalanine treatment CBalsara. et al., 1979),
In direct contrast to these findings, the serotonin
agonist quipazine and the serotonin reuptake blocker ORG 6582
have been reported to convert apomorphine-induced lowintensity sniffing to high-intensity gnawing (Carter and
Pycock, 1978), and cyproheptadine and metergoline have been
reported to reduce apomorphine-induced stereotypy, In addition, parachlorophe.nylalanine, cinanserin and methysergide
treatments have been reported to block :!:_-dopa- or :!:_-tryptophan-induced lateral head weaving and reciprocal forpaw
treading in rats (_Jacobs,

~9742..

Dopamine synthesis inhibi-

tion wi.th alpha-methyltyrosine or receptor blockade with
pimozide apparently had no effect on the stereotypy in
these studies.

Therefore, the role that serotonin may

play in apomorphine-induced ste;r>eotyped behavior remains
very· unclea;r>,
4, Pharmacology of Lergotrile and Related Ergot Compounds
The naturally occuring ergot alkaloids and the hundreds

-

c

of chemically related se.misynthetic agents that are now
available have l'l.een described as a treasure chest of pharmacologically active and clinically useful compounds
(Saameli, l976).

Crude extracts of the parasitic fungus

Claviceps purpure·a have been used for centuries as an
oxytocic, but the cornerstone Of the pharmacology of ergot
is· the classic work done by Sir Henry Dale early in the

sal using ergot extracts in a spinal cat has been the basis
for many studies in receptor pharmacology (for a review
see Schild, 1976}.
The influence of ergot compounds on noradrenergic
synapses has been well studied.

Dihydrogenated ergot alka-

loids. and ergotamine have been demonstrated to have direct
venoconstrictor activity (Mellander and Nordenfelt, 1976).
Aellig Cl976t and Chu and colleagues

Cl976)~

have attributed

part of this venoconstrictor activity to alpha-adrenoceptor
stimulation.

Other noradrenergic effects of ergot compounds

have been dern.onstrated such as presynaptic noradrenaline
release and the blocka.de of alpha-adrenoceptors (Salzmann
and Pacha;_ l9.76l...

Inhibition of catecholamine reuptake has

been dern.onstrated with dihydroergotoxine in central nervous
tissue ()vleier--Ruge and Iwangoff, l976)_.
Recently, rn.uch attention has focused on the dopaminergic activity of ergot compounds, probably due to the
clinical application of ergot compounds in the treatment
of such pathologies as parkinsonism, acromegaly, hyper-

prolactinemia-hypogonadism and puerperal lactation.

The

course of s·tudy on the dopaminergic agonist and antagonist
activities of ergot derivatives and lergotrile have been
explored in two different ways;

0)

those which have employ-

ed biochemical and endocrinological techniques, and ( ii)
th.ose whi.ch have used these compounds clinically as replace.ll)ents for traditional dopaminergic agents.

--------s·everal stud-ies have demonstrated-"Ghe interact-ion o r - - - - - ergot derivatives and lergotrile with the dopamine receptor.
After pretreatment with alpha-methyltyrosine, histochemical
studies on neostriatal and limbic dopamine nerve terminals
revealed a dose-dependent deceleration of dopamine fluorescence in rats treated with. ergocornine or bromocryptine
lCorrodi et al., .l2.73 L.

Lergotrile has also been reported

to slow the decline in dopamine concentration after synthesis
inhibiti.on with alpha-methyltyrosine along with being able
to lower whole. brain DO).'AC l3, 4-dihydroyxphenylacetic acid)
concentration i.n rats (;Fuller and ).'erry, .l9781,

Lergotrile

has been shown to cause a dose-dependant and haloperidolreversible depression of dopami.ne cell-firi.ng rates i.n the
pars compacta o,f the rat substantia nigra (Walters et al,,

.l979_L

All of the.se ob.servations are consi.stent with the

theory that ergol1nes and J ere;otri] e can act as di.rect
dopamine agoni.sts 1.n: Vi.vo.
In

vi.t~o

studi.es i.ndicate that bromocryptine and ler-

gotr:Ue have mixed putative agonist-antagonist activity on

-

-----

-

~~

~~~~ -~~----·~·~~~·-~·~~---~
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dopamine re.ceptors.,

Re.ceptor

b~inding

studi.es. have shown

that lergotrile has' a higher affinity for radiolabeled
dopamine binding than bromocryptine, while bromocqrptine has
a hi_gher affinity than lergotrile for radiolabeled

haloper~
-

idol binding sites (Lew' et al., l9T7L

Lergotrile has also

been shown to antagonize the dopamine-stimulated adenyl
cyclase activity in the striatum (Kebab ian et al. ,1977 L

several categories of pharmacologically distinct dopamine
receptors e.xist 0\eb.abian and Kebabian, 1978)_ and that ler. gotrile posses:se.s varying degrees of agonist-antagonist
properties wi_th respect to these various receptors,
The role of hypothalamic dopamine in inhibiting pituitary prolactin release provides a very good opportunity for
studying the dopaminergic activity of a variety of compounds.
Neuroleptics of many classes (butyrophenones, phenothiazines,
thioxanthines 1 increas.e prolactin secretion in man in a
dos:e"dependent manner without affecting plasma levels of
other pituitary hormones (Langer and Sachar, l977L

This

response to neuroleptics is attributed to the blockade of
dopamine in the. hypothalamic-pituitary axis, as dopamine
completely antagonizes the response to the neuroleptics
wh~en

administered.

Lergotrile has been shown to inhibit

prolacti.n secretton in man and to attenuate the perphenazineinduced sec;r>eti.on of prolactin (Lemberger et al., 127 4 )_.
This effect was ver;r specific; no significant changes in
the other pituitary hormones measured (GH, T3, T4, LH, FSH)

c

21

were observed,

Many ergoline derivatives have been shmm to

have the same effect (Clemens et al., l9741..

The mechanism

of action for lergotrile in prolactin secretion inhib.ition
hasc been suggested to be due to an activation

of adena-

hypophyseal dopamine receptors (Clemens et al., l9 75).

A

major metaboli.te of lergotrile in humans, l3-hydroxy-lergotri.le, has has been demonstrated to be a potent inhibitor
------O-f-P-~O-laC-t-i-r:l-S-e-C-12-e-t-iG-r:l-(+a-!!---l-i~®-t~a-l-.-,-1---9-7-8-}- . - - - - ' - - - - - - - - - - - - - -

Lergotrile has been shown to raise the levels of
serum growth hormone in normal humans, but to lower the hormone in acromegalic patients (Kleinberg et al., 1978; Thorner et al. , 19 7 8l.

Thorner and coworkers (19 7 8) have demon-

strated the dopaminergic nature of thi.s action by attenuating the response to lergotrile with. metoclopramide, a
dopamine antagonist,

Bromocryptine has also been demonstra-

ted to lower serum growth h.ormone in patients with acromegaly (Thorner and Besser, 1976 )..

Both lergotrile and bromo-

cryptine show promi.se in the treatment of acromegaly. Clinical improvement i.s seen as a decrease in sweati.ng, thinning
of extremities, improvement in glucose tolerance and, of
course, decrease in serum growth hormone levels.
Both lergotrile and bromocryptine have been used sue"-.
cessfully in the treatment of parkinsonism (Lieberman et al.,
1975; Goldstein $tal., l978; Klawana et al., 1978).

Bind-

ing studi.es' to striatal membranes have demonstrated that the
efficacy of these compounds in the treatment of parkinsonism
can be attributed to the direct stimulation of dopamine

~-
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receptors. (Goldste.in e.t al., 19}8 L

One particularly

interesting observation in all of these studies: is that
lergotrile and bromocryptine were effective. in patients
who were no longer responsive to L-dopa and carbidopa
therapy.
Certain ergot derivatives: have b.een demonstrated to
induce stereotypy and/or hypoth.ermia in rodents.

Lisuride

-------'h-y-d-r-o-ge-n-m-a-i-e-a-t-e-h-a-s-b-e-en-s-h-.ow-n-t-o-p-r-o-du-c-e-do-s-e-,de-p-en-ele-n-to-------

stereotypy and hypoth.ermia in mice (Horowski and Wachtel,
~9761.

Stereotypy was induced in control as well as

reserpinized mice, indicating a direct dopaminergic action
for this ergot derivative.

A dose-response relationship

has also been demonstrated for b.romocryptine-induced hypoth.ermia in rats (Calne and Claveria, 1975).

It

was suggest-

ed that the hypothermia produced was the result of bromocryptine stimulating dopamine receptors in brain areas controlling body temperature.
Statement of the Problem
Apomorphine and lergotrile induce hypothermia and
stereotypy in the rat.

It is generally accepted that these

ef;fects are due to stimulation of dopamine receptors, as
both effects can be completely antagonized by haloperidol
or pimozide,

Several studies have indicated that such

central actions of dopaminomimeti.cs may be affected by serotonergic mechanisms.
Apomorphine.-induced hypothermia in rats appears to be
mediate.d yia a serotonin link (!}rabowska: et al, ,1973;

23

Grabowska, l974; Cox and Lee, l9792,

One study has in-

dicated that such a serotonin link may mediate apomorphineinduced hyperthermia in rabbits C:Quock and Horita, l97 4 2,
While there are many studies examining the role of serotonin
in apomorphine-induced temperature effects, there are very
few studies that have examined the role of serotonin in
the temperature effects induced by ergot derivatives.

One

-----:s-t-uGl-y--u-s-e-Gi-9-Feme-e-P~:f,_.S--±-ne-t-e-i-nEl-u-c-e-R-y-:fJe-r-t-R-e-P-m-i-a-i-R-r-ab-13-i-t-s:.,-----

and found this effect to be antagonized by treatment with
either parachlorophenylalanine or 5,6-dihydroxytryptamine
(Carruba et al,, l978 I,

The role that serotonin may play

in lergotrile-induced hypothermia has not been studied,
The role that serotonin may play in apomorphineinduced stereotypy i.s very unclear.

This may be due in part

to the difference in methods used to evaluate the behavior
and in part to the absence of a specific agonist or antagonist of serotonin, a problem that plagues many serotonin
studies,

Each of th.e. b.iochemical, pharmacologic and physical

techniques used to facilitate or interrupt serotonergic
activity may affect non-serotonergic nerve. activity as well
(Chase and Murphy, 1973).
Since both apomorphine and lergotrile produce similar
effects which have been attributed to dopaminergic activity,
the possibility exists that both compounds have a similar
mechanism of acti.on.

If this is true, i.t would be expected

that any serotonergic influence on the effects of either drug
would be the same, Th.e pres.ent study was undertaken to compare

=

'=
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two effe,cts induced by apomorphine ()1;ypothermia and
stereotypy) with th,e corresponding effects induced by
lergotrile and the changes that may arise in these responses
when serotonin function is altered.

The results of this

study should provide some evidence as to whether apomorphine and lergotrile produce their effects through a
common or parallel dopamine.rgic mechanism.

Materials and Methoda
~.

Animals
Male Wis.tar rats (Simonsen Laboratories, Gilroy, Calif-

ornial, weighing between 150-250 g, were housed prior to
experimentation in community cages on a standard light-dark
?chedule. (;Light: 0.700-.1400} and given food (S/L Custom Lab
Diet-G4. 5, Simonsen Labs}._ and water ad libitum.
temperature was regulated at 22°

±. ~ °

C,

Ambient

;For each. exper-

iment, naive animals were ch.osen at random, weighed and
placed in individual cages.

Food and water were withheld

during the course of each experiment,
2. Drugs
Apomorphine hydrochloride CAPO,

~~erck

and Co.),

le.rgotrile mesylate (LER, Eli Lillyl, cyproheptadine hydrochloride CC¥P, Merck, Sharp and Dohme), cinanserin hydrochloride CCIN, Squibb, and Sons l., and parachlorophenylalanine methyl ester hydrochloride (PCPA, Sigma) were all

25

26.
pc~epared

u~ing

as aqueous solutions ir.-ll!lediately prior to use

duoble-distilled water. Haloperidol (HAL, McNeil)

was supplied i.n prepared Haldol R injection ampules and
was diluted to final concentration with doub.le-distilled
water,

3. Procedure
All experiments were started at 090.0 with drug and
control pretreatments given by llOO.
water served for control

Double-distilled

inj~_tions_._All

inj_e_c_ti_on.s__w_ere._ _ __

given intraperitoneally with pretreatment and challenge
injections given on opposite sides of the peritoneal cavity.
A constant injection volume of l.O ml/kg was used except for
PCPA and its control, which were given at 2.0 ml/kg.

All

pretreatments were give-n 30 minutes prior to the challenge
injections except for PCPA and its control, which were
given 48 hours prior to challenge injections of APO or LER.
All doses given refer to the salt of the compound except
for HAL, where doses were given as the free base.

The

signi;f:J..cance of the drug effects were evaluated using the
Student't :!:_test,

Analysis of variance between the

base~

line body- temperatures was evaluated us.ing Dunnett 't t test.
4, Measurement of Body Temperature
During experimentati.on, the animals were housed
individually in metal cages (_24

~

30.

~

l5 em) on absorbant

bedding i.n a controlled temperature room (22° ! l° C) after
being weighed.

The animals were allowed to acclimatize for

60 minute.s prior to any temperature recording.

An electron-

27
ic teleth.ermometer with a flexible rectal probe (Yellow
Springs Instruments #43TA, probe #402} 1·;as used for all
temperature measurements, and was inserted 5.0 em past
the rectum (ins·ertion duration = 30 seconds 1.

Baseline

temperatures were taken every 15 minutes for at least one
hour prior to any injection.

Recordings were made 15 and

30 minute.s: after pretreatment injections to assure that

:For APO experiments, recordings were made every 15 minutes
for 20 minutes, and for LER, every 30 minutes for 300
minutes -- this difference reflects the duration of action
of each drug on body temperature.

The change in body

temperature was determined by subtracting each interval's
reading from the baseline temperature for each animal.
5. Measurement of Stereotypy
The animals were housed in clear plexiglass cages
(2')

~

45 x l5 em) in a sUent, evenly lit room for 60

minutes prior to the experiment.

The floor of the cages

was: filled with l-2 em of absorbant bedding (_KC Pharmacal)
upon which the animals could gnaw or bite.

This material

was found to b.e very s.atisfactory to observe the gnawing/
biting component of stereotypy,

Opaque screens were placed

between individual cages to prevent behavioral interaction
between animals.,

In all experiments, the animals were

injected at staggered intervals of 2 minutes, and the
intensity of stereotypy was assessed using a modified
ye;rsion C'I'able l l of the s.cale developed by Costall and

28
Naylor (l972).

A total stereotypy score was assigned to

each animal consisting of the total of the 18 scores
(taken every 5 minutes over the 90-minute observation
period), although very often the duration of stereotypy
was considerably less than 90 minutes.
6. Determination of Brain Serotonin Content
Determination of whole brain serotonin content was
made by spectrofluorimetric assay by the method of Lai
- - - - -

and coworkers (l978l.

Rats were killed by rapid decapita-

tion 48 hours after the double-distilled water or PCPA injections. The entire brain was quickly removed, washed with
tee cold 0.9 percent saline, weighed and homogenized for 4.0
seconds (Brinkmann PCU-2 Polytron) in two volumes of cold
0.3 N perchloric acid.
2000

~

g for lO minutes.

Ths homogenate was centrifuged at
Eight hundredfl of the supernate

was: added to 2.0. ml Na 2HP0 4 buffer containing 0.1 M DEHPA
(diethylhexyphosphoric acid) in 1.2 ml CHC1 . After shaking
3
for two minutes, the organic layer was separated from the
aqueous layer by centrifugation (600

~

g for 5 minutes). One

ml of the organic layer was removed and added to a test tube
containing 2.0 ml heptane and 0.6 ml 0.2 N HCl and shaken
for two minutes. Again the organic layer was separated from
the aqueous layer by centrifugation (600

~

g for 5 minutes).

Two hundred pl of the aqueous layer was transferred to a
test tube to which was added 100 pl o-phthalaldehyde
reagent (50 mg percent in methanol).

This mixture was

29

vortexed immediately.

Eight hundred pl concentrated HCl

(12 NI was then added and vortexed immediately.

The

resulting mixture was heated in an 85° C water bath for
30_ minutes', then cooled to room temperature (22° C2 in
a water bath.

The serotonin phosphor was read at an activa-

tion wavelength of 356 nm and a fluorescence wavelength
of 480 .nm.

Serotonin creatinine sulfate (50 pg/ml in

- - - - - -Q_ ~.l------:-N-M-G-1-)-:-W&-S-U.-S-€-d.-ag--a_g_t-a-r:J.d-a-~d-.-------------------

Results
1. Hypothermia
Apomorphine and lergotrile produced a dose-related
hypothermia when injected intraperitoneally into rats (Fig.
2,3).

Pretreatment with haloperidol 0.5 mg/kg very highly

significantly antagonized the maximum drop in body temperature for both doses of apomorphine (Fig. 4,5) and all
three doses of lergotrile (Fig. 6,7,8) without significantly
affecting body temperature alone (Fig. 9).

Pretreatment

with cyproheptadine HCl 0.5 mg/kg had no significant effect
on apomorphine-induced hypothermia (Fig. 4,5) but significantly potentiated the hypothermic response of lergotrile
(Fig. 6,7,82.

Cyproheptadine HCl 0.5 mg/kg had no sig-

nificant effect on body temperature itself (Fig. 9).

Pre-

treatment with cinanserin HCl 5.0 mg/kg very highly significantly attenuated apomorphine-induced hypothermia (Fig. 10)
while very highly significantly potentiating the hypothermic
response of lergotrile (Fig. 11}.
A single injection of parachlorophenylalanine methyl
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Table II

The effect of pretreatment (-30 minutes) with
either haloperidol (HAL) or cyproheptadine HCl
(CYP) on the body tempera~ure effects of
intraperitoneal apomorphi~e HCl (APO).

Mean body temperature °C + 1.0 SEM
Time,
min.

APO 0.5 mg/kg
(N=14)

HAL 0 . 5 mg/kg
followed by
APO 0.5 mg/kg
(N=8)

CYP 0 . 5 mg/kg
followed by
APO 0.5 mg/kg
(N=lO)

36.83 -+ 0.15

36.73 + 0.18

37.11 + 0 .11

+15

36.44 -+ 0.16

37.06 -+ 0.19

36.60 -+ 0.17

+30

36.32 -+ 0.15

36.95 -+ 0.18

36.54 + 0.22

+45

36.46 + 0.13

36.80 -+ 0.20

36.68 -+ 0.19

+60

36.59 + 0.14

36.81 -+ 0.20

36.75 + 0.18

+75

36.73 -+ 0.15

36.88 -+ 0.19

36.86 -+ 0.17

+90

36.76 -+ 0.17

36.89 +
- 0.18

36.88 -+ 0.13

oa

~

~

azero time values for the three treatment groups were
checked for homogenity using Dunnett's t test, and no
significant difference (P 0. 05) was found (pooled
s2=0,2494, d.f.=292.
-

<

35
Table III -- (Continued)

Mean body temperature °C ~ 1.0 SEM
Time,
min.

CIN 5.0 mg/kg
followed by
APO 2 . 0 mg/kg

--------cN=n-)

PCPA 300 mg/kg
followed by
APO 2 . 0 rng/kg
(N=g-)-~

Q

36.66 + 0.21

37.81 + 0.10

+15

36.21 + 0.31

36.74

+30

36.13 -+ 0.31

36.61 + 0.28

+45

36.27 -+ 0.30

36.73 + 0.26

+60

36.50 + 0.26

37.04 + 0.22

+75

36.63 + 0.20

37.36 + 0.11

+90

36.73 + 0.17

37.59

~

~--

0.27

8----

~

0 .09
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Table IV -- The effect of pretreatment (-30 minutes) with
either haloperidol (HAL) or cyproheptadine HCl
(CYP) on the body temperature effects of
intraperitoneal lergotrile mesylate (LER).

Mean body temperature

0

c + 1.0 SEM
-

Time,
min.

LER 0.3 mg/kg
CN=9}

HAL 0 . 5 mg/kg
followed by
LER 0 . 3 mg/kg
(N=8)

CYP 0 . 5 mg/kg
followed by
LER 0.3 mg/kg
(N=9)

36.17 + 0.22

36.98 -+ 0.26

36.94 + 0.12

+30

35.33 -+ 0.19

36.88 -+ 0. 23

35.93 .:!:. 0.19

+60.

35.31 + 0.20

36.93 -+ 0.20

35.74 + 0.18

+90

35.64 -+ 0.23

36.94 .±_0.23

36.00 + 0.12

+120

35.98 -+ 0.24

36.80 -+ 0.24

36.26 + 0.11

+150

36.17 -+ 0.23

36.83 -+ 0.25

36.51 + 0.16

+180

36.27 + 0 .18

36.98 + 0.20

36.67 + 0.12

+210

36.32 + 0.21

37.09 -+ 0.17

36.76 -+ 0.09

+240

36.28 + 0.24

37.01 -+ 0.17

36.78 -+ 0.08

+270

36.31 .:!:. 0 .~9

36.88 -+ 0. 20

36.89 -+ 0.09

+300

36.~9

37.04 -+ 0.12

36.90 -+ 0.09

oa

+ 0.16

"'

'0--

""'

--

a Zero time values for the three treatment groups were
checked for homogenity using Dunnett's t test, and both
the HAL and the CYp pretreated groups were significantly
d;:rerent (r_ ( 0.:05) from the LER control group (pooled
s -0.3660, d.f.-23).

""'
~

~
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Table V

-- (Continued)

Mean body temperature °C ~ 1.0 SEM
Time,
min.

CIN 5.0 mg/kg
followed by
LER 1.0 mg/kg

PCPA 300 mg/kg
followed by
LER 1.0 mg/kg

--------'(N-=-1-G )------,(N-=-l-1-)----

oa 36.92 + 0.16

37.44 + 0.12

+30

34.99 + 0.14

35.95 + 0.21

+60

34.45

0. 23

35.28 + 0.28

+90

34.63 + 0.24

35.45 + 0.24

+120

35.47

~

0.31

35.65 + 0.22

+150

36.18

~

0.31

36.14 + 0.21

8-o

+180

36.88 + 0.26

36.65 + 0.19

~

+210

37.05 + 0.14

+240

36.92 -+ 0.19
36.84 ~ 0.17

+270

36 .9l

0.13

37.30 + 0.12

+30,0

36.94 + 0.12

37.41 + 0.11

~

~

37.25 + 0.08

"=
"

b

~

~--

4~

Table VI

The effect of pretreatment (-30 minutes) vrith
either haloperidol (HAL) or cyproheptadine HCl
(CYP) on the body temperature effects of
intraperitoneal lergotrile mesylate (LER).

Mean body temperature °C + 1.0 SEM
Time,
min.

oa

LER 3.0 mg/kg
(N=10)

HAL 0 . 5 mg/kg
followed by
LER 3 . 0 mg/kg
(N=9)

CYP 0.5 mg/kg
followed by
LER 3 . 0 mg/kg
(N=9)

36.33 + 0.21

36.52 + 0.24

37.21 + 0.16

±.
±.

±.

0.17

34.96

0.32

35.18 + 0.24

0.17

34.99 -+ 0.33

34.03 + 0.28

33.01 + 0.21

35.48 -+ 0.34

33.71

+30

34.36

+60

33.25

+90

±.

±.

0.25

+120

33.24

0. 23

35.94 -+ 0. 33

33.86 + 0.26

+150

33.68 + 0.28

36.28 -+ 0.28

34.11

+180

34.01

0. 30

36.49 + 0.21

34.44

+210

34.61

0. 31

36.50 + 0.20

34.98

+240

35.01

0. 30

36.59 + 0.20

35.41 + 0.28

+270

35.50

0.30

36.63 + 0. 21

35.78

+300

35.90 -+ 0.27

36.62 -+ 0.18

36.06 + 0.23

±.
±.
±.
±.

±.
±.
±.
±.

0.25

~

0.25
0.29

0.25

azero time values for the three treatment groups were
checked for homogenity using Dunnett 1 s ~ test, and only
the C!P pretreated group was significantly different
CP 0. 05) from the LER control group (pooled s 2=o. 3914,
d-:-f.=25)
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ester HCl 300 mg/kg reduced

~hole

brain serotonin content

to 17 percent of water-pretreated control rats in ~8 hours
(Table VII).

Serotonin depletion with parachlorophenyl-

alanine apparently has no effect on apomorphine-induced
hypothermia (Fig. 10) and may tend to potentiate lergotrile-.
induced hypothermia (not statistically significant, see
Fig. ll).
2. Stereotyped behavior
Apomorphine and lergotrile at low doses induced
stereotypy consisting of increased locomotion coupled with
sniffing and repetitive head and limb movements.

At these

doses, apomorphine produced continuous locomotor activity
and head and limb movements while the locomotor activity
and repetitive movements induced by lergotrile were discontinuous, suggesting that

apomorph~ne

may stimulate the low-

intensity components of stereotypy to a greater extent than
lergotrile.

Increasing the dose of apomorphine or

lergo~·

trile replaced locomotor activity with intermittent biting,
gnawing or licking mouth movements.
phine

High doses of apomor-

or lergotrile evoked continuous (at least 30 seconds

without stopping) biting, gnawing or licking mouth movements.
Mouth movements induced by lergotrile mesylate 1.0 mg/kg
were very continuous, frequently lasting several minutes
without interruption.
The results of haloperidol and cyproheptadine pretreatments on apomorphine- and lergotrile-induced stereotypy are
summarized in Table VIII. Haloperidol produced sl.ight sedation

_
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Table VII

The effect of pretreatment (-48 hours) with
either intraperitoneal double-distilled
water (DH20) or parachlorophenylalanine
methyl ester hydrochloride (PCPA) on the
whole brain serotonin content of male rats.

Treatment, dosage

Mean + 1. 0 SEM

DH20, 2.0 ml/kg

0.465 + 0.023 ug/g

I

N-=-6)

PCPA, 300 mg/kg

(N=6)

0.081 + 0.017 ug/g

t

13.36

p

<0.001

Table VIII -- The effect of pretreatment C-30 minutes) with e~ther haloperidol or
cyproheptadine HCl on stereotyped behavior prodJced by intraperitoneal
apomorphine HCl or lergotrile mesylate in male ~ats ..

Total stereotypy score ± 1.0 SEM dN)
mg/kg

Treatment

Control (H 20)

I

Apomorphine HCl
0.5 mg/kg

Apomorphine ROll
2.0 mg/kg

Lergotrile mesylate
1.0 mg/kg

12.0 + 1.8 (13)

33.2 ± 3.1 (11\)

24.2±2.7(15)

Haloperidol

0.25

2.7 + 0.5b (7)

2.0 + 0.4b (7)

Haloperidol

0.5

1.9 + l.lb (9)

0.9 + 0.3b (9)

Haloperidol

1.0

Cyproheptadine HCl

0.5

8.7±2.7(7)

26.3 ± 4.7 (lj)

Cyproheptadine HCl

1.0

9.1 + 1.4 (10)

18.1 + 4.9a (~0)

Cyproheptadine HCl

2.0

5.3 ± l.lb (9)
4.4 + l.2b (9)

29.9 + 3.2 (10)
35.6 + 3.4a (9)

aSignificantly different from control ( P ( 0. 05)
bvery highly significantly different from control (~ ( 0. 001)
0\
0

;11111111

llli:O

!'1.11

I

I

I '

'I'

'

I

II":!

l~

:I

lll!frllll

lll ..

i.l. : 1·11

·nil

and very highly significantly antagonized both apomorphineand lergotrile-induced stereotypy in a dose-related manner.
Cyproheptadine also reduced the total stereotypy score produced by apomorphine in a dose-related manner.

This antag-

onism became significant as the doses of apomorphine and
cyproheptadine were raised.
no behavioral effects.

Cyproheptadine alone produced

Cyproheptadine had an opposite

------<e-:t'-f'ec-t-on-:teFgutr-1-J:-e=i:n-duced----stereotypy.

A---significant

potentiation of lergotrile-induced stereotypy was observed
as the pretreatment dose of cyproheptadine HCl was increased
to 2.0 mg/kg.

Discussion
The present study indicates that differences exist as
to the effects of known serotonin antagonists (cyproheptadine
and cinanserin) upon the hypothermic and stereotypic effects
of apomorphine and lergotrile.

Pretreatment with cyprohep-

tadine had no effect on apomorphine-induced hypothermia
while it potentiated that of lergotrile, and pretreatment
with cyproheptadine attenuated apomorphine-induced stereotypy while potentiating lergotrile-induced stereotypy. Pretreatment with cinanserin potentiated lergotrile-induced
hypothermia while antagonizing apomorphine-induced hypothermia.

This same pattern was observed with cinanserin in

regard to apomorphine- and lergotrile-induced stereotypy.
Despite the differences that serotonin blockade appears
to have on apomorphine- and lergotrile-induced effects, the
observed effects of these drugs are probably due to some
effect on dopaminergic mechanisms.

Convincing evidence in

the rat exists linking the stimulation of dopamine receptors
to hypothermia (Kruk, 1972; Fuxe and Sjoqvist, 1972) and
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stereotyped behavior (Ernst, 1967; Anden, 1967).

The ability

of the dopamine antagonist haloperidol to abolish the effects
of both apomorphine and lergotrile in the present experiments is presumptive evidence that both apomorphine and
lergotrile exert their effects via dopamine receptors.

This

is in agreement with the consistent findings in rats that
apomorphine induces hypothermia (Barnett et al., 1972; Chiel

as stereotyped behavior (Harnack, 1874; Ernst, 1967; Costall
and Naylor, 19722 and that dopamine antagonists can block
the hypothermic and stereotypic effects of apomorphine (Kruk,
1972; Fuxe and Sjoqvist, 1972; DiChiara and Gessa, 1978).
Until the present investigation, lergotrile-induced hypothermia and stereotypy have not been studied and these effects
have not previously been demonstrated to be attenuated
by neuroleptics.

However, inhibition of unit activity of

dopamine cells by lergotrile has been reported to be antagonized with haloperidol (Walters et al., 1979) and lergotrile
has been found to compete with radiolabeled haloperidol
binding sites in rat striatum (Lew et al., 1977).

Addition-

ally, th.e hypothermic effect of another ergoline, bromocryptine, has been demonstrated to be antagonized by pimazide (Calne et al., 1975).
As both apomorphine and lergotrile appear to exert their
hypothermic and stereotypic effects via dopamine receptors,
the involvement of serotonin in these effects may be due to
three different possibilities.

First, serotonin may be a
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physiological antagonist for the hypothermia and stereotyped
behavior induced by dopaminergic stimulation,

Serotonin

could exert direct opposing action on the target response
(hypothermia or stereotyped behavior) through an independent
pathway or could inhibit the dopaminergic pathways leading
to full expression of the target response.

Second, serotonin

may facilitate the effects of dopaminomimetics on hypothermia

exist as a functional link in the final expression of dopamine.rgic stimulation, or serotonin activation alone could produce an identical response to that of dopaminergic stimulation.

Third, serotonin may have no effect at all upon dop-

aminergic systems since neither cyproheptadine nor cinanserin
can be classified as selective serotonin antagonists ( e.g.
cyproheptadine is also a potent histamine antagonist; see
Stone et al., 19732.
The present findings suggest that serotonin antagonists
attenuate apomorphine-induced hypothermia while facilitating
lergotrile-induced hypothermia.

This proposes a facilitatory

role for serotonin in apomorphine-induced hypothermia and
an antagonistic role for serotonin in lergotrile-induced
hypothermia.

The results with apomorphine in the present

study are in agreement with the results of other investigators.

Cox and Lee (1979) found that intrahypothalamic pre-

treatment with cyproheptadine or methysergide blocked apomorphine- or dopamine-induced hypothermia.

They suggested that

a serotonin link existed in dopamine-receptor-mediated hypo-

thermia in the rat.

In one study (_Grabowska, 1974),

lesions of midbrain raphe prevented apomorphine-induced
hypothermia suggesting that the hypothermic action of apomorphine may be dependent upon activation of serotonin
ne.urons originating in the midbrain.

A serotonergic link

has also been proposed in apomorphine-induced hyperthermia
in the rabbit (Quock and Horita, 1976).

The antagonism of

cinanserin support the theory of a serotonin link mediating
the thermal effects of apomorphine.
If serotonin activation must occur for apomorphine to
induce hypothermia in rats, it would be expected that
serotonin activation alone should induce hypothermia in rats.
Indeed, heat stress accelerates serotonin turnover in rat
brain (Chase and Murphy, 1973).

Additionally, administra-

tion of 5-hydroxytryptophan with a peripheral decarboxylase
inhibitor produced hypothermia in rats (Grabowska et al.,
1973).

This effect has also been demonstrated with trypto-

phan (Pawlowski, 1976), although cyproheptadine and methysergide were shown to potentiate this effect -- an unexpected
finding.

It was suggested that cyproheptadine and methyser-

gide do not block the serotonin receptors for which stimulation leads to hypothermia.

This brings up the possibility

of multiple receptors for both dopamine and serotonin in
producing hypothermia in rats.

Since the serotonin antagon-

ists, cyproheptadine and cinanserin, potentiated lergotrileinduced hypothermia while having the opposite effect on
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apomorphine-induced hypothermia, it is suggested that apomorphine and lergotrile may act through different but parallel
dopaminergic pathways to produce hypothermia in the rat.
A recent body of evidence exists which suggests that
two or more distinct dopamine receptors exist.

Two classes

of dopamine receptors have been defined according to their
association with, or independence from, dopamine-sensitive

has been proposed that those receptors unassociated with
adenyl cyclase be designated type alpha and those receptors
associated with adenyl cyclase be designated type beta
(Kebabian, 1978).

Dopaminergic ergots such as lergotrile,

lisuride, and bromocryptine and specific antagonists such as
metoclopramide have been shown to be relatively specific for
the alpha-dopaminergic receptor in the anterior pituitary,
and fail to produce their effects upon the beta-dopaminergic
receptor in the striatum.
In view of the present findings, it appears that
serotonin may have a facilitatory role on beta-dopaminergic
receptor stimulation (by apomorphine) while antagonizing
alpha-dopaminergic receptor stimulation (by lergotrile). The
inability of parachlorophenylalanine to influence the change
in body temperature induced by apomorphine or lergotrile in
this study does not support this theory, but this lack of
significant results may be due in part to the effect parachlorophenylalanine itself had on the body temperature (see
Tables III and V}.
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The modification of dopaminergic-induced stereotypy by
antiserotonin agents has received extensive investigation,
but lacks agreement.

This may be due to differences in

evaluating the stereotypic behavior(s), the vast number of
chemically different serotonin antagonists used, and differences between species studied.

Several studies have report-

ed the failure of serotonin agonists and antagonists to

et a1., 1972; Baldessarini et al., 1975; Calil et al., 1978).
The present study is in agreement \'lith another study that
demonstrated reduction of apomorphine-induced stereotypy
with the serotonin antagonists cyproheptadine and metergoline (Carter and Pycock, 1978).

Still other studies report

the potentiation of apomorphine-induced stereotypy by seratonin antagonists, indicating an inhibitory role for serotonin in this behavior (Weiner et al., 1975; Baldessarini and
Griffith, 1976; Mogilnicka et al., 1977).

These disagree-

ments preclude the assignment of a single role for serotonin
in apomorphine-induced stereotypy.
As with hypothermia, the antiserotonin effects on apomorphine-induced stereotypy were the opposite of the effects
on lergotrile-induced stereotypy.

This is a further indica-

tion that apomorphine and lergotrile do not stimulate identical dopaminergic pathways.

This difference may involve

the stimulation of adenyl cyclase-linked (beta type) dopamine
receptors by apomorphine and stimulation of non-adenyl
cyclase-linked (alpha type) dopamine receptors by lergotrile
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to produce stereotypy in the rat.

Another possible explan-

ation is that apomorphine and lergotrile stimulate anatomically different dopamine receptor populations with differing serotonergic influence.

Costall and Naylor (1975) have
-

suggested that the tuberculum olfactorium and nucleus
accumbens septi are more important in the low-intensity
components (locomotion, sniffing) of stereotypy while the

the high-intensity (gnawing, licking) components.

In the

present study, it was noted that lergotrile produced more
mouth movements and less locomotion than apomorphine over
the spectrum of doses used.

Others have supported the stim-

ulation of anatomically different receptors by apomorphine
and lergotrile (Tye et al., 1977; Gianutsos and Moore, 1980).
Additionally, much attention has focused on the presynaptic
activity of dopamine agonists (Costall and Naylor, 1973a,
1973b; Silbergeld and Pfeiffer, 1977).

Apomorphine has

been reported to exert less presynaptic activity on dopaminergic neurons than bromocryptine or lergotrile (Silbergeld
and Pfeiffer, l977l.

It is unknown what influence serotonin

may have on the presynaptic events of dopamine neurons, but
if serotonin influences dopamine nerve cell firing, presynaptic actions of ergolines such as dopamine release or
blockage of the reuptake of dopamine might be influenced by
serotonergic manipulation.
The results of this study indicate that the dopamine
agonists apomorphine and lergotrile do not produce their

~

similar effects through a common dopaminergic pathway. It
may be possible that apomorphine and lergotrile activate
two separate dopaminergic pathways, each with its own unique
mode of serotonergic involvement.

There is much evidence

supporting this idea in the literature.

Serotonin appears

to play a facilitatory modulator role in the apomorphineactivated pathway, while serotonin seems to play an inhibi-----~·-·-O-r-.1}-m-OdJJ.-l--a-t-G~I1G-±e-i-R-t--h-8-l-e-rgat-r-i-l-e---a-c-t-±-va-t-e-d-p-at-hway~=-----

both pathways leading to outwardly identical effects of
hypothermia and stereotypy.
:;I::t may be concluded from this investigation that (:!:.)
more than a single dopaminergic pathlqay is involved in producing hypothermia and stereotyped behavior in the rat;
(ii} that these pathways are differentially affected by apomorphine and lergotrile; and (iii) that serotonin is intimately involved in both pathways, albeit in different manners.

Conclusions
The present study in male Wistar rats was designed to
study the mechanisms of two effects (hypothermia and stereotyped behavior) induced by the dopamine agonists apomorphine
and lergotrile.

It is generally accepted that these effects

are produced in rats through central stimulation of dopamine
receptors; however, several studies have indicated that
serotonergic mechanisms may mediate or modify these

11

dopam-

inergic 11 effects.
The results of the present study demonstrate that differences exist as to the effects that known serotonin

antagon~

ists (cyproheptadine and cinanserin) have upon the hypothermic and stereotypic effects of apomorphine and lergotrile.
Pretreatment with cyproheptadine had no effect upon apomorphine-induced hypothermia while it potentiated that of lergotrile.

Moreover, pretreatment with cyproheptadine attenuated

apomorphine-induced stereotypy while potentiating lergotrileinduced stereotypy,

Pretreatment with cinanserin potentiated

lergotrile-induced hypothermia and stereotypy while antagon-

70
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~~

---

-~

~~

izing both of these effects of apomorphine.
Parachlorophenylalanine effectively reduced whole brain
serotonin content in rats, but failed to produce any significant change in the thermal response to apomorphine or lergo-

c

trile.
Haloperidol was found to antagonize both the hypothermia
and stereotypy produced by apomorphine or lergotrile.

This

The present findings suggest that serotonin plays a
facilitatory modulator role in apomorphine-induced effects
and that serotonin plays an inhibitory modulator role in
lergotrile-induced effects.

Recent studies by other investi-

gators have suggested that two or more pharmacologically
and anatomically distinct types of dopamine receptors exist.
It would appear that apomorphine and lergotrile may have the
ability to selectively stimulate these different dopamine
receptor populations.
It may be concluded from this investigation that

(~)

more than a single dopaminergic pathway is involved in producing hypothermia and stereotyped behavior in the rat;
(ii l that these pathways are differentially affected by apomorphine and lergotrile; and (iii} that serotonin is intimately involved in both pathways, albeit in different manners.
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